These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 21595303)

  • 1. [Importance of particle size decrease in the preformulation].
    Szunyogh T; Ambrus R; Szabóné RP
    Acta Pharm Hung; 2011; 81(1):29-36. PubMed ID: 21595303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation of poorly water-soluble Gemfibrozil applying power ultrasound.
    Ambrus R; Naghipour Amirzadi N; Aigner Z; Szabó-Révész P
    Ultrason Sonochem; 2012 Mar; 19(2):286-91. PubMed ID: 21835674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanosuspensions of poorly soluble drugs: preparation and development by wet milling.
    Liu P; Rong X; Laru J; van Veen B; Kiesvaara J; Hirvonen J; Laaksonen T; Peltonen L
    Int J Pharm; 2011 Jun; 411(1-2):215-22. PubMed ID: 21458552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug nanocrystals - Versatile option for formulation of poorly soluble materials.
    Peltonen L; Hirvonen J
    Int J Pharm; 2018 Feb; 537(1-2):73-83. PubMed ID: 29262301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding a relaxation behavior in a nanoparticle suspension for drug delivery applications.
    Deng Z; Xu S; Li S
    Int J Pharm; 2008 Mar; 351(1-2):236-43. PubMed ID: 18093763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine.
    Hecq J; Deleers M; Fanara D; Vranckx H; Amighi K
    Int J Pharm; 2005 Aug; 299(1-2):167-77. PubMed ID: 15996838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Particle design of poorly water-soluble drug substances using supercritical fluid technologies.
    Yasuji T; Takeuchi H; Kawashima Y
    Adv Drug Deliv Rev; 2008 Feb; 60(3):388-98. PubMed ID: 18068261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surface responses and desirability functions to determine optimal granulation domains.
    Giry K; Viana M; Genty M; Wüthrich P; Chulia D
    Drug Dev Ind Pharm; 2010 Sep; 36(9):1016-26. PubMed ID: 20818964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanosizing--oral formulation development and biopharmaceutical evaluation.
    Kesisoglou F; Panmai S; Wu Y
    Adv Drug Deliv Rev; 2007 Jul; 59(7):631-44. PubMed ID: 17601629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Theory and practice of electrospray crystallization in particle size reduction].
    Szunyogh T; Ambrus R; Szabóné Révész P
    Acta Pharm Hung; 2015; 85(2):43-50. PubMed ID: 26390735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of novel chitosan derivatives in dissolution enhancement of a poorly water soluble drug.
    Aiedeh KM; Khatib HA; Taha MO; Al-Zoubi N
    Pharmazie; 2006 Apr; 61(4):306-11. PubMed ID: 16649543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Manufacturing of solid dispersions of poorly water soluble drugs by spray drying: formulation and process considerations.
    Paudel A; Worku ZA; Meeus J; Guns S; Van den Mooter G
    Int J Pharm; 2013 Aug; 453(1):253-84. PubMed ID: 22820134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of single pot and multiphase granulation. Part 2: Effect of the drying process on granules manufactured in a single pot granulator and dried either in situ or in a fluid bed dryer.
    Giry K; Viana M; Genty M; Louvet F; Wüthrich P; Chulia D
    Pharm Dev Technol; 2009; 14(2):149-58. PubMed ID: 19519187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of niflumic acid prepared by rapid microwave-assisted evaporation.
    Radacsi N; Stefanidis GD; Szabó-Révész P; Ambrus R
    J Pharm Biomed Anal; 2014 Sep; 98():16-21. PubMed ID: 24873734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PLGA particle production for water-soluble drug encapsulation: degradation and release behaviour.
    Gasparini G; Holdich RG; Kosvintsev SR
    Colloids Surf B Biointerfaces; 2010 Feb; 75(2):557-64. PubMed ID: 19853423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
    Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanocrystals: comparison of the size reduction effectiveness of a novel combinative method with conventional top-down approaches.
    Salazar J; Ghanem A; Müller RH; Möschwitzer JP
    Eur J Pharm Biopharm; 2012 May; 81(1):82-90. PubMed ID: 22233547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term changes in drug agglomeration within interactive mixtures following blending.
    Andreou JG; Stewart PJ; Morton DA
    Int J Pharm; 2009 May; 372(1-2):1-11. PubMed ID: 19429267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of starch-based pellets by hot-melt extrusion.
    Bialleck S; Rein H
    Eur J Pharm Biopharm; 2011 Oct; 79(2):440-8. PubMed ID: 21570466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible reduction of effective thickness of intestinal unstirred water layer by particle drifting effect.
    Sugano K
    Int J Pharm; 2010 Mar; 387(1-2):103-9. PubMed ID: 20006692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.